Looking Ahead at the Neurology Clinical Trial Space in the Post-COVID-19 Landscape

Life Sciences, Clinical Trials, Pharmaceutical, Patient Recruitment & Retention, Drug Discovery & Development, Medical Device, Medical Device Clinical Trials,
  • Tuesday, April 27, 2021 | 11am EDT (NA) / 4pm BST (UK) / 5pm CEST (EU-Central)
  • 60 min

For pharmaceutical and medical device companies, navigating the neurology clinical trial space in the wake of COVID-19 requires balancing between critical study milestones and patient safety. With the post-pandemic landscape becoming the new clinical trial status quo, neurology research must now execute the best strategies available to adapt and pivot quickly across all central nervous system (CNS) studies.

Common challenges to traditional clinical trials, ranging from recruitment and engagement to treatment and compliance, take on added complexity in the post-COVID-19 landscape. Today’s neurological studies now need to take into account the patient burden, clinical site safety, and even pre-existing neurological conditions caused by the COVID-19 infection to reach successful trial completion.

Register for this webinar to hear experts from Biorasi take a deep dive into what neurological clinical trials will look like beyond COVID-19 protocols, focusing on key topics related to:

  • The recruitment landscape – exploring new solutions for patient enrollment, engagement and diversity across neurological studies
  • The decentralized landscape – assessing and monitoring patient responses using remote solutions to optimize neurological studies
  • The therapeutic landscape – addressing treatment across neurological trials, including examples for Angelman Syndrome and Huntington’s Disease

Speakers

http://Jimmy%20El%20Hokayem,%20Biorasi

Jimmy El Hokayem, Ph.D., Head of the Neurology and Regenerative Medicine Centers of Excellence and Associate Director of Program Development, Biorasi

As head of Biorasi’s Neurology and Regenerative Medicine Centers of Excellence, Dr. El Hokayem oversees clinical projects related to neurological indications and therapies. His unique expertise in the basic, translational and clinical research spectrum provides critical insights at strategic, operational and managerial levels. He is an expert clinical trial decentralizer and an early adopter of digital technologies and digital therapeutics.

With over twenty years’ experience in both academia and clinical research, Dr. El Hokayem has focused his research on rare neurological diseases. He currently serves on the Scientific Advisory Board of the Foundation for Angelman Syndrome Therapeutics (FAST). Dr. El Hokayem has published over twenty peer reviewed papers and received multiple awards from international foundations and entities.

Dr. El Hokayem received his Ph.D. from University of Miami, Miller School of Medicine, in Biochemistry and Molecular Biology. He continued his training with post-doctoral work at the University’s Hussman Institute for Human Genomics.

Message Presenter
http://Ole%20Isacson,%20Harvard%20Medical%20School%20and%20Biorasi

Ole Isacson, MD, Ph.D., Professor of Neurology and Neuroscience at Harvard Medical School and Biorasi Scientific Advisory Board Member – Neurology

Dr. Isacson is a Professor of Neurology and Neuroscience at Harvard Medical School and Founding Director of the Neuroregeneration Institute at McLean Hospital. In this role, he is at the forefront of research into neurodegenerative disease and regenerative medicine for brain disorders. He has served as Executive Scientific Advisory Board Member for the Michael J. Fox Foundation and held memberships in the International Parkinson and Movement Society and the FDA’s Cellular, Tissues and Gene Therapies Advisory Committee.

He received his MD and PhD in Medical Neurobiology from the University of Lund in Sweden, completed his research fellowship in Neuroscience at the University of Cambridge, and holds honorary degrees from both Harvard University and University of Lund.

Message Presenter

Who Should Attend?

  • C-Suite
  • Clinical and Operational Teams
  • Research and Development Teams
  • Digital Health Teams
  • Clinical Trial Management Teams
  • Outsourcing Managers

What You Will Learn

In this webinar, participants will learn about:

  • The recruitment landscape – exploring new solutions for patient enrollment, engagement and diversity across neurological studies
  • The decentralized landscape – assessing and monitoring patient responses using remote solutions to optimize neurological studies
  • The therapeutic landscape – addressing treatment across neurological trials

Xtalks Partner

Biorasi

Biorasi is a customer-focused, full-service, contract research organization (CRO) that delivers fast and flexible solutions across global clinical trials to maximize speed-to-market for its sponsors. As the leader in neurology, nephrology, dermatology, and the rare and urgent disease market, Biorasi sets new benchmarks for speed, agility, and quality in patient enrollment, decentralized trials, and data transparency. To learn more, contact Biorasi at [email protected] / (786) 388-0700.

Media Partner

The original site for employees in the pharma, medical, diagnostic and related industries.  Our hand-curated daily news feed and active message forums will keep you informed.

You Must Login To Register for this Free Webinar

Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.

Create Account